Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,431
archived clinical trials in
Back Pain

Making Better Lives: Patient-Focused Care for Low Back Pain (LBP)
Patient-Centered Versus Imaging-Directed Care for Older Veterans With Chronic LBP
Status: Enrolling
Updated:  12/31/1969
Hunter Holmes McGuire VA Medical Center, Richmond, VA
342
mi
from 43215
Richmond, VA
Making Better Lives: Patient-Focused Care for Low Back Pain (LBP)
Patient-Centered Versus Imaging-Directed Care for Older Veterans With Chronic LBP
Status: Enrolling
Updated: 12/31/1969
Hunter Holmes McGuire VA Medical Center, Richmond, VA
342
mi
from 43215
Richmond, VA
Click here to add this to my saved trials
Treatment of Veterans With Chronic Low Back Pain
Treatment of Veterans With Chronic Low Back Pain
Status: Enrolling
Updated:  12/31/1969
Michael E. DeBakey VA Medical Center, Houston, TX
995
mi
from 43215
Houston, TX
Treatment of Veterans With Chronic Low Back Pain
Treatment of Veterans With Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Michael E. DeBakey VA Medical Center, Houston, TX
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Assessment of Chiropractic Treatment: Strength and Balance
Assessment of Chiropractic Treatment: Strength and Balance
Status: Enrolling
Updated:  12/31/1969
Naval Branch Health Clinic, NATTC
700
mi
from 43215
Pensacola, FL
Assessment of Chiropractic Treatment: Strength and Balance
Assessment of Chiropractic Treatment: Strength and Balance
Status: Enrolling
Updated: 12/31/1969
Naval Branch Health Clinic, NATTC
700
mi
from 43215
Pensacola, FL
Click here to add this to my saved trials
Investigation of Hypermobility, Biomarkers, and Pain Generators in Chronic Pain Patients
Investigation of Hypermobility, Biomarkers, and Pain Generators in Chronic Pain Patients
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center at Houston
990
mi
from 43215
Houston, TX
Investigation of Hypermobility, Biomarkers, and Pain Generators in Chronic Pain Patients
Investigation of Hypermobility, Biomarkers, and Pain Generators in Chronic Pain Patients
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center at Houston
990
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Treatment of Back Pain Using Transcutaneous Magnetic Stimulation (TCMS)
Treatment of Back Pain Using Transcutaneous Magnetic Stimulation (TCMS)
Status: Enrolling
Updated:  12/31/1969
La Toya Stubbs
343
mi
from 43215
Baltimore, MD
Treatment of Back Pain Using Transcutaneous Magnetic Stimulation (TCMS)
Treatment of Back Pain Using Transcutaneous Magnetic Stimulation (TCMS)
Status: Enrolling
Updated: 12/31/1969
La Toya Stubbs
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Feasibility of Using Functional Progression to Guide the Treatment of Adolescent Low Back Pain
Feasibility of Using Functional Progression to Guide the Treatment of Adolescent Low Back Pain
Status: Enrolling
Updated:  12/31/1969
Nationwide Children's Hospital Sports and Ortho PT East Broad
12
mi
from 43215
Columbus, OH
Feasibility of Using Functional Progression to Guide the Treatment of Adolescent Low Back Pain
Feasibility of Using Functional Progression to Guide the Treatment of Adolescent Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Nationwide Children's Hospital Sports and Ortho PT East Broad
12
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
Feasibility of Using Functional Progression to Guide the Treatment of Adolescent Low Back Pain
Feasibility of Using Functional Progression to Guide the Treatment of Adolescent Low Back Pain
Status: Enrolling
Updated:  12/31/1969
Nationwide Children's Hospital Sports and Ortho PT Dublin
10
mi
from 43215
Dublin, OH
Feasibility of Using Functional Progression to Guide the Treatment of Adolescent Low Back Pain
Feasibility of Using Functional Progression to Guide the Treatment of Adolescent Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Nationwide Children's Hospital Sports and Ortho PT Dublin
10
mi
from 43215
Dublin, OH
Click here to add this to my saved trials
Feasibility of Using Functional Progression to Guide the Treatment of Adolescent Low Back Pain
Feasibility of Using Functional Progression to Guide the Treatment of Adolescent Low Back Pain
Status: Enrolling
Updated:  12/31/1969
Nationwide Children's Hospital Sports and Ortho PT New Albany
13
mi
from 43215
New Albany, OH
Feasibility of Using Functional Progression to Guide the Treatment of Adolescent Low Back Pain
Feasibility of Using Functional Progression to Guide the Treatment of Adolescent Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Nationwide Children's Hospital Sports and Ortho PT New Albany
13
mi
from 43215
New Albany, OH
Click here to add this to my saved trials
Feasibility of Using Functional Progression to Guide the Treatment of Adolescent Low Back Pain
Feasibility of Using Functional Progression to Guide the Treatment of Adolescent Low Back Pain
Status: Enrolling
Updated:  12/31/1969
Nationwide Children's Hospital Sports and Orthopedic PT Westerville location
12
mi
from 43215
Westerville, OH
Feasibility of Using Functional Progression to Guide the Treatment of Adolescent Low Back Pain
Feasibility of Using Functional Progression to Guide the Treatment of Adolescent Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Nationwide Children's Hospital Sports and Orthopedic PT Westerville location
12
mi
from 43215
Westerville, OH
Click here to add this to my saved trials
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated:  12/31/1969
The University of California, San Diego
1953
mi
from 43215
La Jolla, CA
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated: 12/31/1969
The University of California, San Diego
1953
mi
from 43215
La Jolla, CA
Click here to add this to my saved trials
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated:  12/31/1969
The Spine Institute
1985
mi
from 43215
Santa Monica, CA
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated: 12/31/1969
The Spine Institute
1985
mi
from 43215
Santa Monica, CA
Click here to add this to my saved trials
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated:  12/31/1969
University of Colorado Hospital
1153
mi
from 43215
Aurora, CO
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated: 12/31/1969
University of Colorado Hospital
1153
mi
from 43215
Aurora, CO
Click here to add this to my saved trials
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated:  12/31/1969
University of Kansas Medical Center
627
mi
from 43215
Kansas City, KA
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated: 12/31/1969
University of Kansas Medical Center
627
mi
from 43215
Kansas City, KA
Click here to add this to my saved trials
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
643
mi
from 43215
Boston, MA
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated:  12/31/1969
Beaumont Health
176
mi
from 43215
Royal Oak, MI
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated: 12/31/1969
Beaumont Health
176
mi
from 43215
Royal Oak, MI
Click here to add this to my saved trials
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
Click here to add this to my saved trials
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated:  12/31/1969
Louis Stokes VA Medical Center
129
mi
from 43215
Cleveland, OH
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated: 12/31/1969
Louis Stokes VA Medical Center
129
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated:  12/31/1969
University Hospitals of Cleveland Medical Center
127
mi
from 43215
Cleveland, OH
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated: 12/31/1969
University Hospitals of Cleveland Medical Center
127
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated:  12/31/1969
Rhode Island Hospital
619
mi
from 43215
Providence, RI
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated: 12/31/1969
Rhode Island Hospital
619
mi
from 43215
Providence, RI
Click here to add this to my saved trials
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated:  12/31/1969
Upstate Clinical Trials
351
mi
from 43215
Spartanburg, SC
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated: 12/31/1969
Upstate Clinical Trials
351
mi
from 43215
Spartanburg, SC
Click here to add this to my saved trials
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated:  12/31/1969
The Center for Pain Relief
134
mi
from 43215
Charleston, WV
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated: 12/31/1969
The Center for Pain Relief
134
mi
from 43215
Charleston, WV
Click here to add this to my saved trials
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated:  12/31/1969
Genesis Research Services
9402
mi
from 43215
Broadmeadow,
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated: 12/31/1969
Genesis Research Services
9402
mi
from 43215
Broadmeadow,
Click here to add this to my saved trials
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated:  12/31/1969
Indiana Spine Group
166
mi
from 43215
Carmel, IN
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated: 12/31/1969
Indiana Spine Group
166
mi
from 43215
Carmel, IN
Click here to add this to my saved trials
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated:  12/31/1969
OrthoIndy
166
mi
from 43215
Indianapolis, IN
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated: 12/31/1969
OrthoIndy
166
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated:  12/31/1969
The Center for Clinical Research
307
mi
from 43215
Winston-Salem, NC
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated: 12/31/1969
The Center for Clinical Research
307
mi
from 43215
Winston-Salem, NC
Click here to add this to my saved trials
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated:  12/31/1969
Northwest Orthopaedic Specialists
1780
mi
from 43215
Spokane, WA
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated: 12/31/1969
Northwest Orthopaedic Specialists
1780
mi
from 43215
Spokane, WA
Click here to add this to my saved trials
MOBile Instruction for Low Back Pain (MOBIL)
Brief Mobile Education at the Point of Care to Influence Healthcare Decisions Related Low Back Pain Management in Primary Care
Status: Enrolling
Updated:  12/31/1969
Brooke Army Medical Center
1134
mi
from 43215
San Antonio, TX
MOBile Instruction for Low Back Pain (MOBIL)
Brief Mobile Education at the Point of Care to Influence Healthcare Decisions Related Low Back Pain Management in Primary Care
Status: Enrolling
Updated: 12/31/1969
Brooke Army Medical Center
1134
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
Parkway Medical Center
482
mi
from 43215
Birmingham, AL
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
Parkway Medical Center
482
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
Boyett Health Services
486
mi
from 43215
Hamilton, AL
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
Boyett Health Services
486
mi
from 43215
Hamilton, AL
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
River Cities Clinical Research Center
788
mi
from 43215
Shreveport, LA
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
River Cities Clinical Research Center
788
mi
from 43215
Shreveport, LA
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
Hassman Research Institute
429
mi
from 43215
Berlin, NJ
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
Hassman Research Institute
429
mi
from 43215
Berlin, NJ
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
National Centers for Pain Management and Research
mi
from 43215
Vestavia Hills, AL
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
National Centers for Pain Management and Research
mi
from 43215
Vestavia Hills, AL
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
Elite Clinical Studies
1656
mi
from 43215
Phoenix, AZ
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
Elite Clinical Studies
1656
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
Phoenix Clinical
1660
mi
from 43215
Phoenix, AZ
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
Phoenix Clinical
1660
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
Noesis Pharma
1654
mi
from 43215
Phoenix, AZ
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
Noesis Pharma
1654
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
Arizona Research Center
1658
mi
from 43215
Phoenix, AZ
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
Arizona Research Center
1658
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
MD Studies, Inc.
1966
mi
from 43215
Fountain Valley, CA
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
MD Studies, Inc.
1966
mi
from 43215
Fountain Valley, CA
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
Neuro-Pain Medical Center
1987
mi
from 43215
Fresno, CA
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
Neuro-Pain Medical Center
1987
mi
from 43215
Fresno, CA
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
Alliance Research Centers
1954
mi
from 43215
Laguna Hills, CA
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
Alliance Research Centers
1954
mi
from 43215
Laguna Hills, CA
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
Clinical Trials Research
2027
mi
from 43215
Lincoln, CA
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
Clinical Trials Research
2027
mi
from 43215
Lincoln, CA
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
Catalina Research Institute, LLC
1942
mi
from 43215
Montclair, CA
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
Catalina Research Institute, LLC
1942
mi
from 43215
Montclair, CA
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
Allied Clinical Research, LLC
2043
mi
from 43215
Sacramento, CA
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
Allied Clinical Research, LLC
2043
mi
from 43215
Sacramento, CA
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
Care Practice
2106
mi
from 43215
San Francisco, CA
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
Care Practice
2106
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
Syrentis Clinical Research
1960
mi
from 43215
Santa Ana, CA
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
Syrentis Clinical Research
1960
mi
from 43215
Santa Ana, CA
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
Universal Pain Management Group
mi
from 43215
Valencia, CA
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
Universal Pain Management Group
mi
from 43215
Valencia, CA
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
Tampa Pain Relief Center-Brandon
mi
from 43215
Brandon, FL
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
Tampa Pain Relief Center-Brandon
mi
from 43215
Brandon, FL
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
International Research Partners, LLC.
990
mi
from 43215
Doral, FL
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
International Research Partners, LLC.
990
mi
from 43215
Doral, FL
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
Dr Vijapura and Associates
669
mi
from 43215
Jacksonville, FL
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
Dr Vijapura and Associates
669
mi
from 43215
Jacksonville, FL
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
Florida Institute of Medical Research
678
mi
from 43215
Jacksonville, FL
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
Florida Institute of Medical Research
678
mi
from 43215
Jacksonville, FL
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
Lake Howell Health Center
mi
from 43215
Maitland, FL
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
Lake Howell Health Center
mi
from 43215
Maitland, FL
Click here to add this to my saved trials